Intravenous Immune Globulin Reduces the IgG Antiendothelial Cell Antibody Response in Kawasaki Disease

References

• Andersen P., Faber V. Antibodies to smooth muscle and other tissue components in infectious mononucleosis. Scandinavian Journal of Infectious Diseases 1978; 10: 1–5
   PubMed Web of Science ®Google Scholar
• Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. The Journal of Clinical Investigation 1973; 52: 2745–2756
   PubMed Web of Science ®Google Scholar
• Kawasaki T., Kosaki F., Okawa S., Shigematsu I., Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54: 271–276
   PubMed Web of Science ®Google Scholar
• Lang B. A., Silverman E. D., Laxer R. M., Rose V. Serum-soluble interleukin-2 receptor levels in Kawasaki disease. The Journal of Pediatrics 1990; 116: 592–596
   PubMed Web of Science ®Google Scholar
• Leung D. Y. M., Collins T., Lapierre L. A., Geha R. S., Pober J. S. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. The Journal of Clinical Investigation 1986; 77: 1428–1435
   PubMed Web of Science ®Google Scholar
• Leung D. Y. M., Cotran R. S., Kurt-Jones E., Burns JC., Newburger J. W., Pober J. S. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. The Lancet 1989; 2: 1298–1302
   PubMed Web of Science ®Google Scholar
• Leung D. Y. M., Geha R. S., Newburger J. W., Burns JC., Fiers W., Lapierre L. A., Pober J. S. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. The Journal of Experimental Medicine 1986; 164: 1958–1972
   PubMed Web of Science ®Google Scholar
• Leung D. Y. M., Moake J. L., Havens P. L., Kim M., Pober J. S. Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome. The Lancet 1988; 2: 183–186
   PubMed Web of Science ®Google Scholar
• Leung D. Y. M. Immunologic aspects of Kawasaki syndrome. The Journal of Rheumatology 1990; 17: 15–18
   Web of Science ®Google Scholar
• Maury C. P. J., Salo E., Pelkonen P. Elevated tumor necrosis factor-a in patients with Kawasaki disease. The Journal of Laboratory and Clinical Medicine 1989; 113: 651–654
   PubMedGoogle Scholar
• Melish M. E., Hicks R. V. Kawasaki syndrome: Clinical features, pathophysiology, etiology and therapy. The Journal of Rheumatology 1990; 17: 2–10, suppl 24
   Web of Science ®Google Scholar
• Newburger J. W., Takahashi M., Burns JC., Beiser A. S., Chung K. J., Duffy E., Glode M. P., Mason W. H., Reddy V., Sanders S. P., Shulman S. T., Wiggins J. W., Hicks R. V., Fulton D. R., Lewis A. B., Leung D. Y. M., Colton T., Rosen F. S., Melish M. E. The treatment of Kawasaki syndrome with intravenous gamma globulin. The New England Journal of Medicine 1986; 315: 341–347
   PubMed Web of Science ®Google Scholar
• Penning C. A., Cunningham J., French M. A. H., Harrison G., Rowell N. R., Hughes P. Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clinical and Experimental Immunology 1984; 58: 548–556
   PubMedGoogle Scholar
• Penning C. A., Hughes P., Rowell N. R. The production of antibody-dependent cellular cytotoxicity by immune complexes in systemic lupus erythematosus. The Journal of Clinical and Laboratory Immunology 1984; 13: 123–127
   PubMedGoogle Scholar
• Rosenbaum J., Pottinger B. E., Woo P., Black C. M., Loizou S., Byron M. A, Pearson J. D. Measurement and characterisation of circulating anti-endothelial cell lgG in connective tissue diseases. Clinical and Experimental Immunology 1988; 72: 450–456
   PubMed Web of Science ®Google Scholar
• Salo E., Pettay O., Pelkonen P. Outbreak of Kawasaki syndrome in Finland. Acta Paediatrica Scandinavica 1986; 75: 75–80
   PubMed Web of Science ®Google Scholar
• Savage C. O. S., Pottinger B. E., Gaskin G., Lockwood C. M., Pusey C. D., Pearson J. D. Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies. Clinical and Experimental Immunology 1991; 85: 14–19
   PubMed Web of Science ®Google Scholar
• Sinclair St N. R.C. Regulation of the immune response. I. Reduction in ability of specific antibody to inhibit long-lasting IgG immunological priming after removal of the Fc fragment. The Journal of Experimental Medicine 1969; 129: 1183–1201
   PubMed Web of Science ®Google Scholar
• Sultan Y., Kazatchkine M. D., Maisonneuve P., Nydegger U. E. Anti-idiotypic suppression of autoantibodies to Factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. The Lancet 1984; 2: 765–768
   PubMed Web of Science ®Google Scholar
• Diagnostic guideline of Kawasaki disease.4th revised edition. Tokyo 1984
   Google Scholar
• Tizard E. J., Baguley E., Hughes G. R. V., Dillon M. J. Antiendothelial cell antibodies detected by a cellular based ELISA in Kawasaki disease. Archives of Disease in Childhood 1991; 66: 189–192
   PubMed Web of Science ®Google Scholar
• Uher F., Dickler H. B. Cooperativity between B lymphocyte membrane molecules: independent ligand occupancy and cross-linking of antigen receptors and Fc> receptors down-regulates B lymphocyte function. The Journal of Immunology 1986; 137: 3124–3129
   PubMed Web of Science ®Google Scholar
• Vaarala O., Palosuo T., Kleemola M., Aho K. Anticardiolipin antibodies in acute infections. Clinical Immunology and Immunopathology 1986; 41: 8–15
   PubMedGoogle Scholar
• Vaarala O., Salo E., Pelkonen P., Palosuo T., Aho K. Anticardiolipin response in Kawasaki disease. Acta Paediatrica Scandinavica 1990; 79: 804–809
   PubMed Web of Science ®Google Scholar
• Vismara A., Meroni P. L., Tincani A., Harris E. N., Barcellini W., Brucato A., Khamashta M., Hughes G. R. V., Zanussi C., Balestrini G. Relationship between anticardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clinical and Experimental Immunology 1988; 74: 247–253
   PubMed Web of Science ®Google Scholar
• Wangel A. G., Kontiainen S., Scheinin T., Schlenzka A., Wangel D., Maenpaa J. Anti-endothelial cell antibodies in insulin-dependent diabetes mellitus. Clinical and Experimental Immunology 1992; 88: 410–413
   PubMed Web of Science ®Google Scholar
• Wangel A. G., Temonen M., Brummer-Korvenkontio M., Vaheri A. Anti-endothelial cell antibodies in Nephro-pathia epidemica and other viral diseases. Clinical and Experimental Immunology 1992, in press
   Web of Science ®Google Scholar
• Williams R., Kunkel H. G. Rheumatoid factor, complement, and conglutinin aberrations in patients with subacute bacterial endocarditis. The Journal of Clinical Investigation 1962; 41: 666–675
   PubMed Web of Science ®Google Scholar
• van der Zee J. M., Heurkens A. H. M., van der Voort E. A. M., Daha M. R., Breedveld F. C. Characterization of anti-endothelial antibodies in patients with rheumatoid arthritis complicated by vasculitis. Clinical and Experimental Rheumatology 1991; 9: 589–594
   PubMed Web of Science ®Google Scholar
• van der Zee J. M., Siegert C. E. H., de Vreede T. A., Daha M. R., Breedveld F. C. Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE). Clinical and Experimental Immunology 1991; 84: 238–244
   PubMed Web of Science ®Google Scholar